(FBRX) |
| 0 (0%) 09-09 14:35 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 90.17 |
| Resistance 1: | 77.20 |
| Pivot price: | 76.90 |
| Support 1: | 76.69 |
| Support 2: | 76.38 |
| 52w High: | |
| 52w Low: |
| EPS | -4.570 |
| Book Value | 7.520 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -37.8 |
| Return on Equity (ttm) | -62.3 |
Tue, 08 Sep 2026
Forte Biosciences, Inc. SEC Filing (Sep 8, 2026) - Stock Titan
Tue, 08 Sep 2026
Forte Biosciences (FBRX) loses Federated Hermes as a shareholder - Stock Titan
Sat, 29 Aug 2026
Forte Biosciences Inc (FBRX) Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Thu, 27 Aug 2026
Forte Biosciences (FBRX) CFO exits stake in $77 argenx buyout - Stock Titan
Fri, 21 Aug 2026
What Forte Biosciences (FBRX) bankers see in $77 cash bid - Stock Titan
Tue, 11 Aug 2026
Hedge Funds Favor argenx (ARGX) Over Forte Biosciences, Inc. (FBRX): Argenx Agrees to Buy Forte Biosciences - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |